Probabilities of overall survival (OS) and progression free survival (PFS) for patients undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplants.
Top line: overall survival of 134 patients undergoing nonmyeloabaltive allografting, Second line: progression-free survival of 134 patients undergoing nonmyeloabaltive allografting, 3rd line: overall survival of 144 patients undergoing myeloablative allografting, 4th line:progression-free survival of 144 patients undergoing myeloablative allografting